S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
$2.13
+4.4%
$3.11
$3.52
$91.00
$1.70M1.16432,822 shs21,530 shs
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$0.07
+18.2%
$0.07
$0.00
$0.12
$17.70M1.7773,459 shs74,475 shs
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
$0.00
$0.00
$0.15
N/AN/AN/AN/A
TRPX
Therapix Biosciences
$0.10
$0.23
$0.25
$4.69
$351KN/A1.59 million shs95,212 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
+4.41%-12.70%-2.29%-9.36%+171.68%
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
+13.84%+18.18%-7.14%+8.33%+62.50%
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
0.00%0.00%0.00%0.00%-96.00%
TRPX
Therapix Biosciences
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
N/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
N/AN/AN/AN/A$0.80 per shareN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
$50K402.97N/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
$25.80M0.00N/AN/AN/ANaN
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
-$9.45MN/A0.00N/AN/A-4,810.77%-130.14%N/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
-$370KN/A0.00N/A5.77%20.61%11.73%N/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
-$1.07MN/A0.00N/AN/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
-$4.79MN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
N/AN/AN/AN/AN/A
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
N/AN/AN/AN/AN/A
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
N/A
0.55
0.55
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
0.10
0.87
0.39
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
N/AN/AN/A
TRPX
Therapix Biosciences
N/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ContraVir Pharmaceuticals Inc stock logo
CTRV
ContraVir Pharmaceuticals
14800,000N/ANot Optionable
Earth Science Tech, Inc. stock logo
ETST
Earth Science Tech
8309.98 million232.80 millionNot Optionable
Parnell Pharmaceuticals Holdings Ltd stock logo
PARNF
Parnell Pharmaceuticals
7882.95 millionN/ANot Optionable
TRPX
Therapix Biosciences
93.51 millionN/ANot Optionable

CTRV, ETST, PARNF, and TRPX Headlines

SourceHeadline
Anixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, PredictionsAnixa Biosciences Stock (NASDAQ:ANIX), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 12 at 5:48 AM
Sagimet Biosciences Inc (SGMT)Sagimet Biosciences Inc (SGMT)
investing.com - August 23 at 7:29 AM
PBIO Pressure BioSciences, Inc.PBIO Pressure BioSciences, Inc.
seekingalpha.com - August 1 at 3:24 PM
Cannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017s IPOsCannabis, Coats, and Social Media: The Good, Bad, and Ugly of 2017's IPOs
thestreet.com - January 19 at 7:59 PM

Media Sentiment Over Time

Company Descriptions

ContraVir Pharmaceuticals logo

ContraVir Pharmaceuticals

NASDAQ:CTRV
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. It engages in the development of TXL, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B; and CRV431, a novel drug candidate for the treatment of chronic HBV infection. The company was founded in 2013 and is headquartered in Edison, New Jersey.
Earth Science Tech logo

Earth Science Tech

OTCMKTS:ETST
Earth Science Tech, Inc. focuses on health and wellness industry. It operates men's health telemedicine platform under brand Peak name; and operates pharmacy. The company offers supplements and topicals products. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
Parnell Pharmaceuticals logo

Parnell Pharmaceuticals

OTCMKTS:PARNF
Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Therapix Biosciences

NASDAQ:TRPX